By Sheri Colberg, PhD
What is a better topic to discuss after the gluttony most of us experience over the Thanksgiving and other fall/winter holidays than carbohydrate loading? (Actually, it probably should be excess calorie consumption in general, but you get the idea.) The following is excerpted from The Athlete’s Guide to Diabetes (2019) and gives you a better understanding of the topic from an exercise physiology (and diabetes) point of view.

Resistant hypertension and type 2 diabetes lead to both microvascular and macrovascular complications. 

Breast milk is deemed to be the “best” for baby, but what are the additional benefits for mothers and their long-term health?

Risk for type 1, type 2 diabetes increased at age <18 years, 18 to 43 years

No metformin recalls affect U.S. market at the moment

Many, many times we have had features on the SGLT-2 inhibitors since the first one was introduced in 2013. We have watched as the research has continued, and we have learned that these medications work to lower blood glucose levels, weight and cardiovascular risk. This week we look more at …

The use of SGLT-2 inhibitors produces cardiovascular benefits and reduces the risk of progression of renal impairment in patients with T2DM. 

Does being a member of a minority ethnicity put you at risk of being overlooked for depression?

While the major impact of hypomagnesemia on cardiovascular outcomes and T2DM has been known, recent evidence suggests that SGLT2 inhibitors may normalize Mg2+ levels.  

Findings seen for progression of coronary artery calcium independent of other cardiovascular risk factors